Skip to main content
Lytix Biopharma AS (FRA:6BG)
Germany flag Germany · Delayed Price · Currency is EUR
0.850
-0.038 (-4.28%)
At close: Dec 5, 2025

Lytix Biopharma AS Revenue

Lytix Biopharma AS had revenue of 377.00K NOK in the twelve months ending September 30, 2025, down -96.50% year-over-year. In the year 2024, Lytix Biopharma AS had annual revenue of 11.13M with 178.98% growth.

Revenue (ttm)
377.00K NOK
Revenue Growth
-96.50%
P/S Ratio
1,839.64
Revenue / Employee
47.13K NOK
Employees
8
Market Cap
59.18M EUR

Revenue Chart

* This company reports financials in NOK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202411.13M7.14M178.98%
Dec 31, 20233.99M-7.04M-63.82%
Dec 31, 202211.03M-8.28M-42.87%
Dec 31, 202119.31M15.23M373.91%
Dec 31, 20204.07M-2.27M-35.73%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SAP SE 36.49B
Siemens Aktiengesellschaft 78.91B
Allianz SE 105.02B
Deutsche Telekom AG 121.02B
Siemens Energy AG 39.08B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München 62.10B
Rheinmetall AG 11.00B
Deutsche Bank Aktiengesellschaft 29.86B
Revenue Rankings